Semaglutide in overweight non-diabetic peritoneal dialysis patients: a real-world single-center experience.

IF 2.6 4区医学 Q2 UROLOGY & NEPHROLOGY

Journal of Nephrology Pub Date : 2025-10-08 DOI:10.1007/s40620-025-02453-9

Giuseppe Paribello, Fortuna Papa, Maria Chiara Ganzerli, Antonio Pisani, Eleonora Riccio

引用次数: 0

查看原文本刊更多论文

西马鲁肽在超重非糖尿病腹膜透析患者中的应用：真实世界的单中心体验。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Nephrology 医学-泌尿学与肾脏学

CiteScore

5.60

自引率

5.90%

发文量

289

审稿时长

3-8 weeks

期刊介绍： Journal of Nephrology is a bimonthly journal that considers publication of peer reviewed original manuscripts dealing with both clinical and laboratory investigations of relevance to the broad fields of Nephrology, Dialysis and Transplantation. It is the Official Journal of the Italian Society of Nephrology (SIN).